SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001341004-16-000982
Filing Date
2016-01-06
Accepted
2016-01-06 17:08:59
Documents
4
Period of Report
2016-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 38079
2 EXHIBIT 99.1 - PRESS RELEASE ex99-1.htm EX-99.1 19198
3 logo.jpg GRAPHIC 18589
4 logo_small.jpg GRAPHIC 3926
  Complete submission text file 0001341004-16-000982.txt   89996
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 161327618
SIC: 2834 Pharmaceutical Preparations